DE1420015B1
(de)
*
|
1959-10-16 |
1971-08-26 |
Boehringer Sohn Ingelheim |
2'-Hydroxy-5,9-dimethyl-6,7-benzomorphane
|
GB1202148A
(en)
|
1968-03-06 |
1970-08-12 |
Sankyo Co |
Pharmaceutical compositions
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
US3884916A
(en)
*
|
1971-03-30 |
1975-05-20 |
Janssen Pharmaceutica Nv |
2,2-Diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides
|
US3714159A
(en)
*
|
1971-03-30 |
1973-01-30 |
Janssen Pharmaceutica Nv |
2,2-diaryl-4-(4'-aryl-4'-hydroxy-piper-idino)-butyramides
|
US4326074A
(en)
*
|
1972-09-22 |
1982-04-20 |
William H. Rorer, Inc. |
Amidinoureas
|
US4025652A
(en)
*
|
1975-03-31 |
1977-05-24 |
William H. Rorer, Inc. |
Amidinoureas
|
US3937801A
(en)
*
|
1973-07-10 |
1976-02-10 |
American Home Products Corporation |
Reducing the incidence of gastrointestinal side effects during the treatment of inflammatory conditions with antiinflammatory drugs
|
US4060635A
(en)
|
1975-03-31 |
1977-11-29 |
William H. Rorer, Inc. |
Amidinoureas for treating diarrhea
|
US4203920A
(en)
*
|
1975-03-31 |
1980-05-20 |
William H. Rorer, Inc. |
Amidinoureas
|
US4066654A
(en)
*
|
1975-04-16 |
1978-01-03 |
G. D. Searle & Co. |
1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
|
US4072686A
(en)
*
|
1975-04-16 |
1978-02-07 |
G. D. Searle & Co. |
1-(3,3,3-Triarylalkyl)-4-phenyl-piperidinealkanols
|
US3996214A
(en)
|
1976-02-23 |
1976-12-07 |
G. D. Searle & Co. |
5-(1,1-Diphenyl-4-(cyclic amino) but-2-trans-en-1-yl)-2-alkyl-1,3,4-oxadiazoles and intermediates thereto
|
US4013668A
(en)
*
|
1976-03-10 |
1977-03-22 |
G. D. Searle & Co. |
5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds
|
US4012393A
(en)
*
|
1976-03-22 |
1977-03-15 |
G. D. Searle & Co. |
2-[5-(CYCLIC AMINO) ETHYL-10,11-DIHYDRO-5H-dibenzo[a,d]-cyclohepten-5- yl]-5
|
US4115400A
(en)
|
1976-05-27 |
1978-09-19 |
Eli Lilly And Company |
1-Azoniabicyclo[3.1.0]hexanes
|
GB1593191A
(en)
|
1977-03-23 |
1981-07-15 |
Reckitt & Colmann Prod Ltd |
Derivatives of morphine
|
US4125531A
(en)
|
1977-04-18 |
1978-11-14 |
G. D. Searle & Co. |
2-Substituted-1-azabicyclo[2.2.2]octanes
|
US4069223A
(en)
*
|
1977-05-02 |
1978-01-17 |
G. D. Searle & Co. |
4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
|
US4116963A
(en)
|
1977-05-23 |
1978-09-26 |
G.D. Searle & Co. |
3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy piperidines and related compounds
|
US4194045A
(en)
*
|
1977-12-27 |
1980-03-18 |
G. D. Searle & Co. |
1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds
|
IT1096665B
(it)
|
1978-06-14 |
1985-08-26 |
Tecnofarmaci Spa |
Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza
|
US4176186A
(en)
|
1978-07-28 |
1979-11-27 |
Boehringer Ingelheim Gmbh |
Quaternary derivatives of noroxymorphone which relieve intestinal immobility
|
JPS5535031A
(en)
*
|
1978-09-04 |
1980-03-11 |
Shin Etsu Chem Co Ltd |
Enteric coating composition
|
US4311833A
(en)
*
|
1979-03-06 |
1982-01-19 |
Daicel Chemical Industries Ltd. |
Process for preparing ethylcarboxymethylcellulose
|
US4277605A
(en)
|
1980-03-07 |
1981-07-07 |
Bristol-Myers Company |
Chemical compounds
|
US4322426A
(en)
*
|
1980-04-28 |
1982-03-30 |
E. I. Du Pont De Nemours And Company |
17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
US4466968A
(en)
|
1980-11-24 |
1984-08-21 |
Dermall, Ltd. |
Method for prophylaxis or treatment of emesis and nausea
|
US4427676A
(en)
*
|
1980-12-19 |
1984-01-24 |
John Wyeth & Brother Ltd. |
Thiomorpholine derivatives
|
US4377568A
(en)
*
|
1981-08-12 |
1983-03-22 |
Merck Sharp & Dohme (I.A.) Corp. |
Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
|
DK150008C
(da)
*
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
US4870084A
(en)
|
1982-03-16 |
1989-09-26 |
Pfizer Inc. |
Bicyclic benzo fused pyran compounds used for nausea treatment and prevention
|
US4987136A
(en)
*
|
1982-03-16 |
1991-01-22 |
The Rockefeller University |
Method for controlling gastrointestinal dysmotility
|
DE3381877D1
(de)
|
1982-03-16 |
1990-10-18 |
Univ Rockefeller |
Verwendung von opium antagonisten zur herstellung von arzneimitteln zur behebung gastro-intestinaler stoerungen.
|
US4430327A
(en)
*
|
1982-05-18 |
1984-02-07 |
Eli Lilly And Company |
Method for treating pregnant females for pain and anxiety
|
US4457907A
(en)
*
|
1982-08-05 |
1984-07-03 |
Clear Lake Development Group |
Composition and method for protecting a therapeutic drug
|
US4533739A
(en)
|
1982-10-12 |
1985-08-06 |
G. D. Searle & Co. |
2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity
|
US4518433A
(en)
*
|
1982-11-08 |
1985-05-21 |
Fmc Corporation |
Enteric coating for pharmaceutical dosage forms
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
US4462839A
(en)
*
|
1983-06-16 |
1984-07-31 |
Fmc Corporation |
Enteric coating for pharmaceutical dosage forms
|
US4556552A
(en)
*
|
1983-09-19 |
1985-12-03 |
Colorcon, Inc. |
Enteric film-coating compositions
|
DE3474511D1
(en)
*
|
1983-11-01 |
1988-11-17 |
Terumo Corp |
Pharmaceutical composition containing urokinase
|
US4689332A
(en)
|
1984-04-09 |
1987-08-25 |
Research Corporation |
Growth regulation and related applications of opioid antagonists
|
US5266574A
(en)
*
|
1984-04-09 |
1993-11-30 |
Ian S. Zagon |
Growth regulation and related applications of opioid antagonists
|
US4666716A
(en)
|
1984-09-04 |
1987-05-19 |
Richardson-Vicks Inc. |
Antidiarrheal compositions and use thereof
|
JPS6229515A
(ja)
*
|
1985-07-30 |
1987-02-07 |
Shinjiro Tsuji |
硬カプセル剤のフイルムコ−テイング方法
|
JPH0676314B2
(ja)
|
1985-09-30 |
1994-09-28 |
花王株式会社 |
坐剤基剤及び坐剤
|
US4824853A
(en)
*
|
1985-10-11 |
1989-04-25 |
Janssen Pharmaceutica N.V. |
α,α-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides and method of treating diarrhea
|
US4806556A
(en)
*
|
1985-12-12 |
1989-02-21 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
US4730048A
(en)
*
|
1985-12-12 |
1988-03-08 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
US4861781A
(en)
*
|
1986-03-07 |
1989-08-29 |
The University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
US4719215A
(en)
*
|
1986-03-07 |
1988-01-12 |
University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
DE3609073C2
(de)
|
1986-03-18 |
1995-08-10 |
Hans J Prof Dr Rer Nat Schmitt |
Meßeinrichtung zur nichtinvasiven Feststellung peripherer Abfluß- und Durchflußstörungen in menschlichen Extremitäten
|
US4990521A
(en)
*
|
1986-07-03 |
1991-02-05 |
Janssen Pharmaceutica |
4-(aroylamino)piperidine-butanimide derivatives
|
JP2593501B2
(ja)
*
|
1986-08-28 |
1997-03-26 |
コーテクス・リミテッド |
動物成長促進剤
|
US5597564A
(en)
*
|
1986-08-28 |
1997-01-28 |
Enzacor Properties Limited |
Method of administering a microgranular preparation to the intestinal region of animals
|
US4888346A
(en)
*
|
1986-10-07 |
1989-12-19 |
Bernard Bihari |
Method for the treatment of persons infected with HTLV-III (AIDS) virus
|
US4765978A
(en)
|
1986-12-16 |
1988-08-23 |
Schering Corporation |
Novel vaginal suppository
|
FR2609632B1
(fr)
|
1987-01-21 |
1991-03-29 |
Shelly Marc |
Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
|
NL8700842A
(sl)
|
1987-04-10 |
1988-11-01 |
Duphar Int Res |
|
US4891379A
(en)
*
|
1987-04-16 |
1990-01-02 |
Kabushiki Kaisha Kobe Seikosho |
Piperidine opioid antagonists
|
IL83086A
(en)
|
1987-07-06 |
1991-03-10 |
Teva Pharma |
Stable,injectable solutions of vincristine salts
|
US4857833A
(en)
*
|
1987-08-27 |
1989-08-15 |
Teradyne, Inc. |
Diagnosis of faults on circuit board
|
CA1315689C
(en)
|
1987-09-03 |
1993-04-06 |
Leon I. Goldberg |
Quarternary derivatives of noroxymorphone which relieve nausea and emesis
|
ATE78687T1
(de)
|
1987-09-10 |
1992-08-15 |
Univ Chicago |
Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
|
US4912114A
(en)
*
|
1988-03-18 |
1990-03-27 |
Sandoz Ltd. |
Morphinan derivatives
|
SG64368A1
(en)
*
|
1988-06-30 |
1999-04-27 |
Astra Ab |
Dermorphin analogs their methods of preparation pharmaceutical compositions and methods of therapeutic treatment using the same
|
JPH0653683B2
(ja)
|
1988-07-14 |
1994-07-20 |
ザ ロックフェラー ユニバーシティ |
慢性痛あるいは慢性咳を治療する経口用組成物
|
EP0352361A1
(en)
|
1988-07-29 |
1990-01-31 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
US4999342A
(en)
*
|
1988-08-16 |
1991-03-12 |
Ortho Pharmaceutical Corporation |
Long lasting contraceptive suppository composition and methods of use
|
US4857533A
(en)
|
1988-12-15 |
1989-08-15 |
Baker Cummins Pharmaceuticals, Inc. |
Method of treatment for autoimmune diseases
|
US4863928A
(en)
|
1989-01-04 |
1989-09-05 |
Baker Cummins Pharmaceuticals, Inc. |
Method of treatment for arthritic and inflammatory diseases
|
US5102887A
(en)
*
|
1989-02-17 |
1992-04-07 |
Arch Development Corporation |
Method for reducing emesis and nausea induced by the administration of an emesis causing agent
|
US5116868A
(en)
*
|
1989-05-03 |
1992-05-26 |
The Johns Hopkins University |
Effective ophthalmic irrigation solution
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
US5236947A
(en)
|
1990-02-28 |
1993-08-17 |
Jouveinal S.A. |
Propanamines, their pharmacological properties and their application as an antidiarrheal
|
JPH0813748B2
(ja)
|
1990-04-23 |
1996-02-14 |
帝國製薬株式会社 |
大腸崩壊性ポリペプチド系経口製剤
|
KR970005839B1
(ko)
|
1990-05-11 |
1997-04-21 |
화이자 인코포레이티드 |
상승 치료효과를 얻기 위한 조성물 및 방법
|
US5780012A
(en)
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
JP3160862B2
(ja)
|
1990-11-15 |
2001-04-25 |
雪印乳業株式会社 |
骨強化食品、飼料及び医薬
|
JPH04230625A
(ja)
*
|
1990-12-27 |
1992-08-19 |
Standard Chem & Pharmaceut Corp Ltd |
噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
|
WO1992014364A1
(en)
|
1991-02-25 |
1992-09-03 |
Conan Kornetsky |
Opiate receptor antagonist modulates hyperkinetic movement disorder
|
JP2916290B2
(ja)
|
1991-03-22 |
1999-07-05 |
帝國製薬株式会社 |
生理活性ポリペプチド含有大腸崩壊経口製剤
|
US5250542A
(en)
|
1991-03-29 |
1993-10-05 |
Eli Lilly And Company |
Peripherally selective piperidine carboxylate opioid antagonists
|
US5270328A
(en)
*
|
1991-03-29 |
1993-12-14 |
Eli Lilly And Company |
Peripherally selective piperidine opioid antagonists
|
CA2064373C
(en)
|
1991-03-29 |
2005-08-23 |
Buddy Eugene Cantrell |
Piperidine derivatives
|
US5159081A
(en)
|
1991-03-29 |
1992-10-27 |
Eli Lilly And Company |
Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
|
US5220017A
(en)
|
1991-04-10 |
1993-06-15 |
Merck & Co., Inc. |
Cholecystokinin antagonists
|
ES2109362T3
(es)
*
|
1991-06-21 |
1998-01-16 |
Univ Cincinnati |
Unas proteinas administrables oralmente y metodo para hacerlas.
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
US5614219A
(en)
*
|
1991-12-05 |
1997-03-25 |
Alfatec-Pharma Gmbh |
Oral administration form for peptide pharmaceutical substances, in particular insulin
|
US5256154A
(en)
*
|
1992-01-31 |
1993-10-26 |
Sterling Winthrop, Inc. |
Pre-filled plastic syringes and containers and method of terminal sterilization thereof
|
JPH05213763A
(ja)
|
1992-02-10 |
1993-08-24 |
Sanwa Kagaku Kenkyusho Co Ltd |
易吸収活性化カルシウム製剤
|
JPH06508641A
(ja)
|
1992-04-10 |
1994-09-29 |
フセソユズニ ナウチノ−イススレドバテルスキ インスティテュト メディツィンスキフ ポリメロフ |
医薬組成物
|
US5686072A
(en)
|
1992-06-17 |
1997-11-11 |
Board Of Regents, The University Of Texas |
Epitope-specific monoclonal antibodies and immunotoxins and uses thereof
|
USRE36547E
(en)
*
|
1992-09-21 |
2000-02-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
|
US5580876A
(en)
*
|
1992-09-21 |
1996-12-03 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
US6096756A
(en)
*
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
US5512578A
(en)
*
|
1992-09-21 |
1996-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
|
US5472943A
(en)
*
|
1992-09-21 |
1995-12-05 |
Albert Einstein College Of Medicine Of Yeshiva University, |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
|
RO119721B1
(ro)
|
1992-10-28 |
2005-02-28 |
Genentech Inc. |
Antagonişti ai factorului de creştere al celulelor vasculare endoteliale
|
ES2095001T5
(es)
*
|
1992-12-22 |
2001-03-16 |
Univ Cincinnati |
Una composicion terapeutica administrable oralmente y su metodo de obtencion.
|
DE4303214A1
(de)
|
1993-02-04 |
1994-08-11 |
Wolfgang Marks |
Behandlung von Erkrankungen viraler, viroidaler oder onkogener Genese durch Steroid-Saponine oder deren Aglykone
|
US5585348A
(en)
|
1993-02-10 |
1996-12-17 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia
|
US5656290A
(en)
*
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5391372A
(en)
*
|
1993-06-28 |
1995-02-21 |
Campbell; Elizabeth |
Methods of treating colic and founder in horses
|
JP3843456B2
(ja)
|
1993-07-23 |
2006-11-08 |
東レ株式会社 |
モルヒナン誘導体および医薬用途
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
GB2281205A
(en)
|
1993-08-24 |
1995-03-01 |
Euro Celtique Sa |
Oral opioid analgesic
|
SE9303744D0
(sv)
*
|
1993-11-12 |
1993-11-12 |
Astra Ab |
Pharmaceutical emulsion
|
US5434171A
(en)
|
1993-12-08 |
1995-07-18 |
Eli Lilly And Company |
Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
|
US6190691B1
(en)
*
|
1994-04-12 |
2001-02-20 |
Adolor Corporation |
Methods for treating inflammatory conditions
|
AU2360195A
(en)
*
|
1994-05-05 |
1995-11-29 |
Beckman Instruments, Inc. |
Oligonucleotide repeat arrays
|
IT1269826B
(it)
*
|
1994-05-24 |
1997-04-15 |
Paolo Minoia |
Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
|
US5536507A
(en)
*
|
1994-06-24 |
1996-07-16 |
Bristol-Myers Squibb Company |
Colonic drug delivery system
|
US5866154A
(en)
*
|
1994-10-07 |
1999-02-02 |
The Dupont Merck Pharmaceutical Company |
Stabilized naloxone formulations
|
US5614222A
(en)
*
|
1994-10-25 |
1997-03-25 |
Kaplan; Milton R. |
Stable aqueous drug suspensions and methods for preparation thereof
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5578725A
(en)
|
1995-01-30 |
1996-11-26 |
Regents Of The University Of Minnesota |
Delta opioid receptor antagonists
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
US6096763A
(en)
|
1995-02-23 |
2000-08-01 |
Merck & Co., Inc. |
α1a adrenergic receptor antagonists
|
US6025154A
(en)
*
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
US5714586A
(en)
*
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
US5821219A
(en)
|
1995-08-11 |
1998-10-13 |
Oregon Health Sciences University |
Opioid antagonists and methods of their use
|
GB9517001D0
(en)
|
1995-08-18 |
1995-10-18 |
Denny William |
Enediyne compounds
|
US5804595A
(en)
*
|
1995-12-05 |
1998-09-08 |
Regents Of The University Of Minnesota |
Kappa opioid receptor agonists
|
EP0780372B3
(en)
|
1995-12-21 |
2013-05-22 |
Syngenta Participations AG |
3-Amino-2-mercaptobenzoic acid derivatives and processes for their preparation
|
ATE250931T1
(de)
|
1996-02-15 |
2003-10-15 |
Janssen Pharmaceutica Nv |
Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
|
EP0914097B1
(en)
|
1996-03-12 |
2002-01-16 |
Alza Corporation |
Composition and dosage form comprising opioid antagonist
|
US6136780A
(en)
|
1996-03-29 |
2000-10-24 |
The Penn State Research Foundation |
Control of cancer growth through the interaction of [Met5 ]-enkephalin and the zeta (ζ) receptor
|
US20040024006A1
(en)
*
|
1996-05-06 |
2004-02-05 |
Simon David Lew |
Opioid pharmaceutical compositions
|
DE19651551C2
(de)
|
1996-12-11 |
2000-02-03 |
Klinge Co Chem Pharm Fab |
Opioidantagonisthaltige galenische Formulierung
|
US20010036469A1
(en)
|
1997-01-13 |
2001-11-01 |
Gooberman Lance L. |
Opiate antagonist implant and process for preparation therefor
|
PL190293B1
(pl)
†
|
1997-02-14 |
2005-11-30 |
Goedecke Ag |
Sposób stabilizowania naloksonu i jego soli, stały półstały lub ciekły lek, zawierający nalokson i jego sole oraz zastosowanie środków stabilizujących do zapobiegania dimeryzacji naloksonu
|
US6884879B1
(en)
*
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
US6329516B1
(en)
|
1997-04-28 |
2001-12-11 |
Fmc Corporation |
Lepidopteran GABA-gated chloride channels
|
GB9801231D0
(en)
*
|
1997-06-05 |
1998-03-18 |
Merck & Co Inc |
A method of treating cancer
|
HU9701081D0
(en)
*
|
1997-06-23 |
1997-08-28 |
Gene Research Lab Inc N |
Pharmaceutical composition of antitumoral activity
|
US6525038B1
(en)
*
|
1997-06-24 |
2003-02-25 |
Werner Kreutz |
Synergistic compositions for the selective control of tumor tissue
|
US6353004B1
(en)
*
|
1997-07-14 |
2002-03-05 |
Adolor Coporation |
Peripherally acting anti-pruritic opiates
|
US6096764A
(en)
|
1997-08-21 |
2000-08-01 |
Eli Lilly And Company |
Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
|
US6099853A
(en)
|
1997-09-04 |
2000-08-08 |
Protein Express |
Vaginal suppository vaccine for urogenital infections
|
ATE210983T1
(de)
†
|
1997-11-03 |
2002-01-15 |
Stada Arzneimittel Ag |
Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
|
US6559158B1
(en)
*
|
1997-11-03 |
2003-05-06 |
Ur Labs, Inc. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
|
AU2003204844B2
(en)
|
1997-11-03 |
2007-06-07 |
Arch Development Corporation |
Use of methylnaltrexone and related compounds
|
US6274591B1
(en)
*
|
1997-11-03 |
2001-08-14 |
Joseph F. Foss |
Use of methylnaltrexone and related compounds
|
US20030158220A1
(en)
*
|
1997-11-03 |
2003-08-21 |
Foss Joseph F. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
|
US5972954A
(en)
|
1997-11-03 |
1999-10-26 |
Arch Development Corporation |
Use of methylnaltrexone and related compounds
|
US6777534B1
(en)
|
1997-12-09 |
2004-08-17 |
Children's Medical Center Corporation |
Peptide antagonists of vascular endothelial growth factor
|
RU2241458C2
(ru)
|
1997-12-22 |
2004-12-10 |
Эро-Селтик, С.А. |
Комбинации агонист/антагонист опиоида
|
EP0930334A1
(en)
|
1998-01-16 |
1999-07-21 |
Quest International B.V. |
Polysaccharide conjugate capable of binding cellulose
|
AU3596599A
(en)
|
1998-01-26 |
1999-08-09 |
Unilever Plc |
Method for producing antibody fragments
|
GB9802251D0
(en)
|
1998-02-03 |
1998-04-01 |
Ciba Geigy Ag |
Organic compounds
|
PT1068870E
(pt)
*
|
1998-04-03 |
2006-10-31 |
Ajinomoto Kk |
Agentes antitumorais
|
DE19818802A1
(de)
|
1998-04-27 |
1999-10-28 |
Dresden Arzneimittel |
Stabile Mitoxantron-Lösungen
|
US6359111B1
(en)
*
|
1998-05-28 |
2002-03-19 |
Neorx Corporation |
Opioid receptor targeting
|
HN1999000149A
(es)
*
|
1998-09-09 |
2000-01-12 |
Pfizer Prod Inc |
Derivados de 4,4-biarilpiperidina
|
US20010010919A1
(en)
|
1998-10-13 |
2001-08-02 |
David K. Grandy |
Opioid antagonists and methods of their use
|
BR9916765A
(pt)
|
1999-01-05 |
2001-09-25 |
Unilever Nv |
Processo para produzir um material imunoadsorvente, uso de uma proteìna que é ligada por meio de uma ligação covalente a um fragmento de anticorpo, material imunadsorvente, uso de um material, e, kit de teste diagnóstico
|
ATE276359T1
(de)
|
1999-01-19 |
2004-10-15 |
Unilever Nv |
Verfahren zur herstellung von antikörperfragmenten
|
CA2293008A1
(en)
|
1999-01-28 |
2000-07-28 |
Hong Qi |
Premixed alatrofloxacin injectable compositions
|
CA2361678A1
(en)
|
1999-02-05 |
2000-08-10 |
Rijksuniversiteit Leiden |
Method of modulating metabolite biosynthesis in recombinant cells
|
US6194382B1
(en)
|
1999-03-03 |
2001-02-27 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists
|
JP4049477B2
(ja)
|
1999-03-23 |
2008-02-20 |
大鵬薬品工業株式会社 |
副作用軽減剤
|
WO2000065057A1
(en)
|
1999-04-22 |
2000-11-02 |
Unilever Plc |
Inhibition of viral infection using monovalent antigen-binding proteins
|
US7129265B2
(en)
|
1999-04-23 |
2006-10-31 |
Mason R Preston |
Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
|
US6171620B1
(en)
|
1999-04-27 |
2001-01-09 |
Health Research, Inc. |
Method of enhancing the efficacy of anti-tumor agents
|
AU4564200A
(en)
|
1999-04-29 |
2000-11-17 |
Aventis Pharma S.A. |
Method for treating cancer using camptothecin derivatives and 5-fluorouracil
|
US6833349B2
(en)
|
1999-06-08 |
2004-12-21 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating inflammatory skin diseases
|
US20020068712A1
(en)
|
1999-07-23 |
2002-06-06 |
Troy Stevens |
Use of decreasing levels of functional transient receptor potential gene product
|
US20030105121A1
(en)
|
1999-07-27 |
2003-06-05 |
Bernard Bihari |
Method of preventing lipodystrophy syndrome or reversing a pre-existing syndrome in HIV-infected patients being treated with antiretroviral agents
|
IL147920A0
(en)
|
1999-08-02 |
2002-08-14 |
Keygene Nv |
Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants
|
EP1206264A2
(en)
*
|
1999-08-25 |
2002-05-22 |
Barrett R. Cooper |
Compositions and methods for treating opiate intolerance
|
HUP0203623A2
(hu)
|
1999-08-31 |
2003-02-28 |
Grünenthal GmbH |
Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
|
US6451806B2
(en)
*
|
1999-09-29 |
2002-09-17 |
Adolor Corporation |
Methods and compositions involving opioids and antagonists thereof
|
AU776567B2
(en)
|
1999-11-01 |
2004-09-16 |
Evans, Brian K |
Composition for treatment of constipation and irritable bowel syndrome
|
ATE306281T1
(de)
*
|
1999-11-04 |
2005-10-15 |
Roussy Inst Gustave |
Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
|
US6469030B2
(en)
*
|
1999-11-29 |
2002-10-22 |
Adolor Corporation |
Methods for the treatment and prevention of ileus
|
ES2329004T3
(es)
|
1999-11-29 |
2009-11-20 |
Adolor Corporation |
Nuevos procedimientos para el tratamiento y la prevencion de ileo.
|
DK1244447T3
(da)
|
1999-11-29 |
2007-04-23 |
Adolor Corp |
Nye fremgangsmåder og sammensætninger indeholdende opioider og deres antagonister
|
US6384044B1
(en)
|
1999-11-29 |
2002-05-07 |
Bernard Bihari |
Method of treating cancer of the prostate
|
WO2001041705A2
(en)
*
|
1999-11-29 |
2001-06-14 |
Adolor Corporation |
Novel methods for the treatment and prevention of dizziness and pruritus
|
US6911455B2
(en)
*
|
1999-12-22 |
2005-06-28 |
Smithkline Beecham Corporation |
Methods for preparing pharmaceutical formulations
|
US6545010B2
(en)
|
2000-03-17 |
2003-04-08 |
Aventis Pharma S.A. |
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
|
US20010046968A1
(en)
|
2000-03-23 |
2001-11-29 |
Zagon Ian S. |
Opioid growth factor modulates angiogenesis
|
US6967075B2
(en)
*
|
2000-04-07 |
2005-11-22 |
Schering Corporation |
HCV replicase complexes
|
WO2001085257A2
(en)
|
2000-05-05 |
2001-11-15 |
Pain Therapeutics, Inc. |
Opioid antagonist compositions and dosage forms
|
SI1296714T1
(sl)
*
|
2000-06-22 |
2010-01-29 |
S For Entpr University Of Iowa |
Kombinacija CpG-ja in protiteles, usmerjenih proti CD19, CD20, CD22 ali CD40 za zdravljenje ali preprečevanje raka
|
EP1175905A1
(en)
|
2000-07-24 |
2002-01-30 |
Societe Des Produits Nestle S.A. |
Nutritional Composition
|
FI116089B
(sv)
*
|
2000-07-27 |
2005-09-15 |
Johan Tore Karlstroem |
Anordning och förfaranden vid reglar
|
RU2241462C2
(ru)
|
2000-07-28 |
2004-12-10 |
Ф. Хоффманн-Ля Рош Аг |
Новая фармацевтическая композиция
|
JP4183371B2
(ja)
|
2000-08-31 |
2008-11-19 |
日本・バイオ株式会社 |
発酵ウコンの製造法
|
NZ507152A
(en)
*
|
2000-09-27 |
2001-06-29 |
Hiltive Pty Ltd |
Wall cladding assembly with cladding having recesses along opposite sides to engage with flanges of support members
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
JP2002229183A
(ja)
*
|
2000-12-01 |
2002-08-14 |
Hoya Corp |
リソグラフィーマスクブランク及びその製造方法
|
EP1229130B1
(en)
|
2000-12-04 |
2013-11-20 |
Primagen B.V. |
Tests based on nucleic acids of endosymbiont cellular organelles
|
AU3938402A
(en)
|
2000-12-13 |
2002-06-24 |
Lilly Co Eli |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
UA73619C2
(en)
|
2000-12-13 |
2005-08-15 |
Pfizer Prod Inc |
Stable pharmaceutical compositions of nmda receptor agonist (variants) and method of treatment
|
KR100405161B1
(ko)
|
2000-12-14 |
2003-11-12 |
신풍제약주식회사 |
록소프로펜 함유 근육주사제 조성물
|
GB0100115D0
(en)
|
2001-01-04 |
2001-02-14 |
Alchemia Pty Ltd |
Delivery systems
|
US6693125B2
(en)
*
|
2001-01-24 |
2004-02-17 |
Combinatorx Incorporated |
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
|
KR20040018341A
(ko)
|
2001-03-23 |
2004-03-03 |
샤이어 바이오켐 인코포레이티드 |
암치료용 약제 조성물
|
US20040242523A1
(en)
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
CA2443694A1
(en)
|
2001-04-09 |
2002-10-17 |
Progenics Pharmaceuticals, Inc. |
Anti-cd19 immunotoxins
|
NZ528994A
(en)
*
|
2001-04-26 |
2006-02-24 |
Control Delivery Sys Inc |
Sustained release drug delivery system containing codrugs
|
ATE446751T1
(de)
*
|
2001-06-05 |
2009-11-15 |
Univ Chicago |
Verwendung von methylnaltrexon zur behandlung von immunsuppression
|
CA2463733C
(en)
|
2001-08-31 |
2011-03-22 |
Eugene A. Woltering |
Inhibition of angiogenesis and destruction of angiogenic vessels with extracts of noni juice (morinda citrifolia)
|
PT1436012T
(pt)
*
|
2001-10-18 |
2018-03-27 |
Nektar Therapeutics |
Conjugados poliméricos de antagonistas de opióides
|
US20030144312A1
(en)
|
2001-10-30 |
2003-07-31 |
Schoenhard Grant L. |
Inhibitors of ABC drug transporters in multidrug resistant cancer cells
|
WO2003037365A1
(en)
*
|
2001-11-01 |
2003-05-08 |
The Johns Hopkins University |
Methods and compositions for treating vascular leak using hepatocyte growth factor
|
CA2470519C
(en)
*
|
2001-12-21 |
2009-11-17 |
Merck & Co., Inc. |
Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
|
AU2002368150A1
(en)
|
2002-02-04 |
2004-02-25 |
Jonathan Moss |
Use of methylnaltrexone in treating gastrointestinal dysfunction in equines
|
US20050011468A1
(en)
*
|
2002-02-04 |
2005-01-20 |
Jonathan Moss |
Use of methylnaltrexone in treating gastrointestinal dysfunction in equines
|
US7074825B2
(en)
|
2002-03-07 |
2006-07-11 |
Huanbiao Mo |
Composition and method for treating cancer
|
CN1652752A
(zh)
†
|
2002-03-14 |
2005-08-10 |
欧罗赛铁克股份有限公司 |
盐酸纳曲酮组合物
|
US20030191147A1
(en)
*
|
2002-04-09 |
2003-10-09 |
Barry Sherman |
Opioid antagonist compositions and dosage forms
|
US7355081B2
(en)
|
2002-04-17 |
2008-04-08 |
The University Of North Carolina At Chapel Hill |
Curcumin analogues and uses thereof
|
AU2003273176A1
(en)
|
2002-05-17 |
2003-12-12 |
Board Of Regents, The University Of Texas System |
Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
|
US7012100B1
(en)
|
2002-06-04 |
2006-03-14 |
Avolix Pharmaceuticals, Inc. |
Cell migration inhibiting compositions and methods and compositions for treating cancer
|
US6986901B2
(en)
*
|
2002-07-15 |
2006-01-17 |
Warner-Lambert Company Llc |
Gastrointestinal compositions
|
US20040010997A1
(en)
*
|
2002-07-17 |
2004-01-22 |
Oren Close |
Guides to align masonry walls defining apertures, and methods of use
|
US7160913B2
(en)
*
|
2002-09-13 |
2007-01-09 |
Thomas Jefferson University |
Methods and kit for treating Parkinson's disease
|
US7691374B2
(en)
*
|
2002-10-23 |
2010-04-06 |
Health Research, Inc. |
Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody
|
MXPA05004759A
(es)
|
2002-11-08 |
2005-08-02 |
Mallinckrodt Inc |
Proceso para la preparacion de sales alcaloides n-alquil morfinan cuaternarias.
|
AU2003296954A1
(en)
|
2002-12-13 |
2004-07-09 |
The Regents Of The University Of California |
Analgesic combination comprising nalbuphine
|
WO2004054569A1
(en)
*
|
2002-12-16 |
2004-07-01 |
Council Of Scientific And Industrial Research |
Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings
|
TW200500067A
(en)
*
|
2003-01-21 |
2005-01-01 |
Control Delivery Sys Inc |
Salts of codrugs and uses related thereto
|
BRPI0408108A
(pt)
|
2003-03-07 |
2006-03-01 |
Lilly Co Eli |
composto, composição farmacêutica, métodos para bloquear em receptor mu, kappa, delta ou uma combinação de receptores dos mesmos em um mamìfero, para tratar ou prevenir obesidade e doenças relacionadas e para suprimir apetite, e, uso de um composto
|
DK2368553T3
(en)
†
|
2003-04-08 |
2015-02-09 |
Progenics Pharm Inc |
Pharmaceutical preparation comprising methylnaltrexone
|
MXPA05010819A
(es)
*
|
2003-04-08 |
2006-03-30 |
Progenics Pharm Inc |
Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
|
JP2006522819A
(ja)
*
|
2003-04-08 |
2006-10-05 |
プロジェニックス ファーマシューティカルズ,インコーポレーテッド |
緩下薬および末梢オピオイドアンタゴニストを組み合わせた便秘の組み合わせ療法
|
HUE034290T2
(en)
|
2003-04-29 |
2018-02-28 |
Orexigen Therapeutics Inc |
Preparations containing opioid antagonist and bupropion to affect weight loss
|
US6992193B2
(en)
|
2003-06-10 |
2006-01-31 |
Adolor Corporation |
Sulfonylamino phenylacetamide derivatives and methods of their use
|
PT1644021E
(pt)
*
|
2003-06-13 |
2013-01-30 |
Ironwood Pharmaceuticals Inc |
Métodos e composições para o tratamento de distúrbios gastrointestinais
|
US7494979B2
(en)
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
AU2003903387A0
(en)
|
2003-07-02 |
2003-07-17 |
Sirtex Medical Limited |
Combination therapy for treatment of neoplasia
|
JP2007509722A
(ja)
*
|
2003-10-29 |
2007-04-19 |
アレズ フィジオニックス リミテッド |
超音波流体の流動中心線を決定するための方法および装置
|
US8946262B2
(en)
|
2003-12-04 |
2015-02-03 |
Adolor Corporation |
Methods of preventing and treating gastrointestinal dysfunction
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
EP1701699B1
(en)
|
2003-12-19 |
2011-07-13 |
Schering Corporation |
Pharmaceutical compositions of an A2a receptor antagonist
|
JP4225922B2
(ja)
|
2004-01-15 |
2009-02-18 |
アキレス株式会社 |
ポリオレフィン系樹脂発泡体シート
|
CA2556223A1
(en)
*
|
2004-03-10 |
2005-09-22 |
Trustees Of Tufts College |
Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
|
TW200533339A
(en)
|
2004-03-16 |
2005-10-16 |
Bristol Myers Squibb Co |
Therapeutic synergy of anti-cancer compounds
|
US6946556B1
(en)
|
2004-05-21 |
2005-09-20 |
Acura Pharmaceuticals, Inc. |
Preparation of opioid analgesics by a one-pot process
|
US7094775B2
(en)
|
2004-06-30 |
2006-08-22 |
Bone Care International, Llc |
Method of treating breast cancer using a combination of vitamin D analogues and other agents
|
US7388008B2
(en)
*
|
2004-08-02 |
2008-06-17 |
Ambrilia Biopharma Inc. |
Lysine based compounds
|
US20060063792A1
(en)
*
|
2004-09-17 |
2006-03-23 |
Adolor Corporation |
Substituted morphinans and methods of their use
|
EP1799713B1
(en)
|
2004-09-23 |
2014-11-05 |
VasGene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
ES2392645T3
(es)
|
2004-09-30 |
2012-12-12 |
Becton,Dickinson And Company |
Método para reducir o eliminar residuos en una recipiente médico de vidrio y recipiente hecho de acuerdo con el mismo
|
CN101137378A
(zh)
*
|
2005-01-20 |
2008-03-05 |
普罗热尼奇制药公司 |
甲基纳曲酮和相关化合物治疗术后胃肠功能障碍的用途
|
US8524731B2
(en)
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
US9662390B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
US20080194611A1
(en)
|
2005-06-03 |
2008-08-14 |
Alverdy John C |
Modulation of Cell Barrier Dysfunction
|
US20070059272A1
(en)
|
2005-06-03 |
2007-03-15 |
The University Of Chicago |
Modulation of microbial pathogen-host cell interactions
|
CA2609985A1
(en)
|
2005-06-03 |
2007-05-10 |
The University Of Chicago |
Modulation of cell barrier dysfunction
|
AU2006258060A1
(en)
|
2005-06-09 |
2006-12-21 |
Mallinckrodt Inc. |
Method for separation and purification of naltrexone by preparative chromatography
|
PE20070207A1
(es)
*
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
US20070060501A1
(en)
*
|
2005-08-30 |
2007-03-15 |
Khem Jhamandas |
Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070259939A1
(en)
|
2006-05-04 |
2007-11-08 |
Accelerated Technologies |
Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness
|
WO2008011596A2
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophilic abuse deterrent delivery system
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
TW200815451A
(en)
*
|
2006-08-04 |
2008-04-01 |
Wyeth Corp |
6-carboxy-normorphinan derivatives, synthesis and uses thereof
|
WO2008021394A2
(en)
|
2006-08-15 |
2008-02-21 |
Theraquest Biosciences, Llc |
Pharmaceutical formulations of cannabinoids and method of use
|
TW200817048A
(en)
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
JP2010510328A
(ja)
|
2006-11-22 |
2010-04-02 |
プロジェニックス ファーマスーティカルス インコーポレーテッド |
7,8−飽和−4,5−エポキシ−モルフィナニウム類似体の(r)−n−立体異性体
|
CN101636400A
(zh)
|
2006-11-22 |
2010-01-27 |
普罗基因制药公司 |
用于合成季4,5-环氧-吗啡烷类似物以及分离出它们的n-立体异构体的方法
|
CA2670342A1
(en)
|
2006-11-22 |
2008-06-12 |
Progenics Pharmaceuticals, Inc. |
N-oxides of 4,5-epoxy-morphinanium analogs
|
TW200843802A
(en)
|
2007-02-09 |
2008-11-16 |
Drugtech Corp |
Compositions for improving gastrointestinal nutrient and drug absorption
|
CA2682129A1
(en)
|
2007-03-29 |
2008-10-09 |
Progenics Pharmaceuticals, Inc. |
Crystal forms and uses thereof
|
WO2008121348A2
(en)
|
2007-03-29 |
2008-10-09 |
Progenics Pharmaceuticals, Inc. |
Peripheral opioid receptor antagonists and uses thereof
|
ES2493590T3
(es)
|
2007-03-29 |
2014-09-12 |
Wyeth Llc |
Antagonistas de receptores opioides periféricos y usos de los mismos
|
KR20110004425A
(ko)
|
2008-05-07 |
2011-01-13 |
넥타르 테라퓨틱스 |
말초적 작용 오피오이드 길항제의 경구 투여
|
CA2676881C
(en)
†
|
2008-09-30 |
2017-04-25 |
Wyeth |
Peripheral opioid receptor antagonists and uses thereof
|
JP5213763B2
(ja)
|
2009-03-03 |
2013-06-19 |
キヤノン株式会社 |
レンズ鏡筒及びそれを有する光学機器
|
CN107308125B
(zh)
|
2010-03-11 |
2021-07-16 |
惠氏有限责任公司 |
甲基纳曲酮的口服制剂和亲脂盐
|